CXCR4 and prostate carcinoma: Interestingly, CXCR4 is also a relevant molecular marker in cancer, as it is overexpressed in more than 20 human malignancies including the highly prevalent lung, breast, pancreas, ovarian, colorectal, hepatic and prostate cancers, as well as some forms of leukemia and lymphoma [45–48].